OverviewSuggest Edit

Pharmaron (康龙化成) is a company operating as a contract research organization that supports the life science industry. It provides customers with pharmaceutical research and development services. The company specializes in synthetic, medicinal, and analytical chemistry, biology, pharmacology, drug safety assessment, and more.

TypePublic
Founded2004
HQBeijing, CN
Websitepharmaron.com
Employee Ratings3.2

Latest Updates

Employees (est.) (Jun 2020)9,113(+24%)
Revenue (FY, 2019)¥3.8 B(+30%)
Share Price (Jan 2021)¥156.3 (+9%)
Cybersecurity ratingBMore

Key People/Management at Pharmaron

Boliang Lou

Boliang Lou

Chairman & CEO
Larry Lou

Larry Lou

President & COO
Bei Zheng

Bei Zheng

Executive Vice President
Hua Yang

Hua Yang

Chief Scientific Officer
Katherine Lee

Katherine Lee

Senior Vice President Strategic Partnership
Gilbert Li

Gilbert Li

Chief Financial Officer
Show more

Pharmaron Office Locations

Pharmaron has offices in Beijing, Ningbo, Shanghai, Tianjin and in 8 other locations
Beijing, CN (HQ)
6 Taihe Road
Beijing, CN
32 Kexue Yuan Road, Zhongguancun Life Science Park, Changping District
Ningbo, CN
Bldg 6, Tongji Industry Park, No. 7 of Binhai 2 Rd, Hangzhou Bay New Area
Shanghai, CN
3rd Fl, 2727 Jinke Rd, Pudong Xinqu
Tianjin, CN
81 Xin-Ye Seven Street, TEDA West Area
Xi'an, CN
No.1, 12th Fengcheng Road, Xi'an Export Processing Zone
Show all (13)

Pharmaron Financials and Metrics

Pharmaron Revenue

Embed Graph
View revenue for all periods
Pharmaron's revenue was reported to be ¥3.76 b in FY, 2019 which is a 29.2% increase from the previous period.
CNY

Revenue (H1, 2020)

2.2b

Gross profit (H1, 2020)

794.4m

Gross profit margin (H1, 2020), %

36.2%

Net income (H1, 2020)

466.6m

Market capitalization (22-Jan-2021)

122.4b

Closing stock price (22-Jan-2021)

156.3

Cash (30-Sept-2020)

2.9b

EV

120.0b
Pharmaron's current market capitalization is ¥122.4 b.
Annual
CNYFY, 2017FY, 2018FY, 2019

Revenue

2.3b2.9b3.8b

Revenue growth, %

27%29%

Cost of goods sold

2.0b2.4b

Gross profit

774.5m948.1m1.3b
Half Year
CNYH1, 2019H1, 2020

Revenue

1.6b2.2b

Cost of goods sold

1.1b1.4b

Gross profit

522.4m794.4m

Gross profit Margin, %

32%36%
Annual
CNYFY, 2017FY, 2018FY, 2019

Cash

307.2m4.4b

Accounts Receivable

604.0m857.1m

Prepaid Expenses

32.2m33.0m

Inventories

70.1m97.1m
Quarterly
CNYQ1, 2020Q2, 2020Q3, 2020

Cash

3.5b3.0b2.9b

Accounts Receivable

761.5m967.2m973.5m

Prepaid Expenses

42.1m

Inventories

113.4m129.6m130.0m
Annual
CNYFY, 2018FY, 2019

Depreciation and Amortization

315.9m374.6m

Inventories

(12.2m)(27.9m)

Accounts Payable

16.6m8.1m

Cash From Operating Activities

790.7m938.6m
Half Year
CNYH1, 2019H1, 2020

Depreciation and Amortization

179.7m205.6m

Inventories

(11.9m)(34.7m)

Accounts Payable

12.1m46.1m

Cash From Operating Activities

252.3m617.9m
Show all financial metrics

Pharmaron Operating Metrics

FY, 2019H1, 2020

Clients (R&D Service Platform)

1.04 k

New Clients (R&D Service Platform)

192 190

Preclinical Projects (CMC Services)

485 292

Projects (CMC Services)

568 463
Show all operating metrics

Pharmaron Acquisitions / Subsidiaries

Company NameDateDeal Size
LinkStartJuly 03, 2020
Shin Nippon Biomedical Laboratories Clinical Pharmacology Center, Inc.February 28, 2017
Xceleron IncJanuary 10, 2017
Quotient BioresearchFebruary 11, 2016
Bridge Laboratories ChinaJanuary 11, 2010
Beijing Xirui Biotechnology Co., Ltd
CR Medicon Research, Inc.
Nanjing Sirui Biotechnology Co., Ltd
Nanjing Ximaidi Medical Technology Co., Ltd.(
Phamaron (Tianjin) Process Development and Manufacturing Co., Ltd
Show more

Pharmaron Revenue Breakdown

Embed Graph

Pharmaron revenue breakdown by business segment: 63.3% from Laboratory Services, 24.0% from CMC Services, 12.1% from Clinical Development Services and 0.5% from Other

Pharmaron revenue breakdown by geographic segment: 23.1% from Europe, 12.7% from Mainland China , 58.8% from North America and 5.3% from Other

Pharmaron Cybersecurity Score

Cybersecurity ratingPremium dataset

B

80/100

SecurityScorecard logo

Pharmaron Online and Social Media Presence

Embed Graph

Pharmaron News and Updates

Pharmaron Acquires Majority Ownership in LinkStart

Pharmaron, a fully integrated contract research and manufacturing organization offering end-to-end R&D services for the life science industry, announced today that it completed a follow-on investment to acquire the majority ownership in Beijing LinkStart SMO Ltd.(Linkstart), a third party clinic…

Pharmaron Lists H-Shares on the Hong Kong Stock Exchange

Pharmaron Beijing Co., Ltd. (Stock Code: 300759.SZ/3759.HK) announced today that 117 million H-shares are listed on the Main Board of The Stock Exchange of Hong Kong. This is equivalent to HK$4.344 billion raised based on the offer price of HK$39.5 per share (assuming the Over-allotment Option is no…

Pharmaron and Bayer Enter Global Collaboration Agreement

Pharmaron entered into a global collaboration agreement with Bayer to develop new molecular entities for veterinary medicines. Under the collaboration, Bayer will fully leverage Pharmaron’s Chemistry, Manufacturing and Controls (CMC) service platform. This will include drug substance and drug produc…

Pharmaron Acquires Majority Stake in CR Medicon

Pharmaron, a fully integrated contract research organization offering R&D services for the life science industry, announced today that it has completed a follow-on investment in CR Medicon Holding Inc. (together with its wholly owned subsidiary, Nanjing CR Medicon Pharmaceutical Technology Co., …

Pharmaron Frequently Asked Questions

  • When was Pharmaron founded?

    Pharmaron was founded in 2004.

  • Who are Pharmaron key executives?

    Pharmaron's key executives are Boliang Lou, Larry Lou and Bei Zheng.

  • How many employees does Pharmaron have?

    Pharmaron has 9,113 employees.

  • What is Pharmaron revenue?

    Latest Pharmaron annual revenue is ¥3.8 b.

  • What is Pharmaron revenue per employee?

    Latest Pharmaron revenue per employee is ¥412.3 k.

  • Who are Pharmaron competitors?

    Competitors of Pharmaron include WuXi AppTec, Akums and Lotus Pharmaceutical.

  • Where is Pharmaron headquarters?

    Pharmaron headquarters is located at 6 Taihe Road, Beijing.

  • Where are Pharmaron offices?

    Pharmaron has offices in Beijing, Ningbo, Shanghai, Tianjin and in 8 other locations.

  • How many offices does Pharmaron have?

    Pharmaron has 13 offices.